Similar articles

• Screening and breast cancer.

  Gøtzsche PC. Gøtzsche PC. N Engl J Med. 2006 Feb 16;354(7):767-9; author reply 767-9. N Engl J Med. 2006. PMID: 16482679 No abstract available.
• Effect of screening and adjuvant therapy on mortality from breast cancer.

  Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ; Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Berry DA, et al. N Engl J Med. 2005 Oct 27;353(17):1784-92. doi: 10.1056/NEJMoa050518. N Engl J Med. 2005. PMID: 16251534
• Mortality reduction by breast-cancer screening.

  Voogd AC, Coebergh JW. Voogd AC, et al. Lancet. 2003 Jul 19;362(9379):245-6. doi: 10.1016/S0140-6736(03)13920-7. Lancet. 2003. PMID: 12885492 No abstract available.
• Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem.

  Feuer EJ. Feuer EJ. J Natl Cancer Inst Monogr. 2006;(36):2-6. doi: 10.1093/jncimonographs/lgj002. J Natl Cancer Inst Monogr. 2006. PMID: 17032887 Review. No abstract available.
• [Current status of adjuvant chemotherapy for breast cancer].

  Takeuchi H, Okubo K, Fujiuchi N, Saeki T. Takeuchi H, et al. Gan To Kagaku Ryoho. 2006 Jun;33(6):736-41. Gan To Kagaku Ryoho. 2006. PMID: 16770090 Review. Japanese.